Abstract
A new, rapid and simple procedure based on dispersive liquid-liquid microextraction (DLLME) of the Cr(VI) chelate with ammonium pyrrolidine dithiocarbamate (APDC) and subsequent ICP-MS analysis of the extracts by using dried-droplet laser ablation (LA) sample introduction was developed for the determination of ultratrace amounts of Cr(VI). DLLME was performed using 1 mL of methanol containing 50 μL of CCl4 as extraction mixture. Several factors influencing the DLLME performance of Cr(VI), such as sample pH, concentration of APDC and effect of potential interferents were established. Dried microdroplets (7 μL) of the obtained extracts were ablated from a polystyrene substrate and quantitated by ICP-MS. External calibration was used in combination with platinum (195Pt) as an internal standard. No matrix-matched standards are required to perform quantitative analysis. Proposed methodology yields sufficiently low detection limits (0.11 and 0.31 μg L-1 for 52Cr and 53Cr, respectively) with precision between 4 and 8%. The method was applied to determine Cr(VI) in tap and river samples. The spike recoveries showed acceptable performance of the method, with all of the recoveries within 7% of the nominal spike values.
Keywords: Dispersive liquid-liquid microextraction, Cr(VI), Dried-droplet laser ablation, ICP-MS, Water analysis.
Current Analytical Chemistry
Title:Determination of Cr(VI) by Dispersive Liquid-Liquid Microextraction and Dried-Droplet Laser Ablation ICP-MS
Volume: 6 Issue: 4
Author(s): Ina Razmislevicien, Audrius Padarauskas, Birut Pranaityt and Evaldas Naujalis
Affiliation:
Keywords: Dispersive liquid-liquid microextraction, Cr(VI), Dried-droplet laser ablation, ICP-MS, Water analysis.
Abstract: A new, rapid and simple procedure based on dispersive liquid-liquid microextraction (DLLME) of the Cr(VI) chelate with ammonium pyrrolidine dithiocarbamate (APDC) and subsequent ICP-MS analysis of the extracts by using dried-droplet laser ablation (LA) sample introduction was developed for the determination of ultratrace amounts of Cr(VI). DLLME was performed using 1 mL of methanol containing 50 μL of CCl4 as extraction mixture. Several factors influencing the DLLME performance of Cr(VI), such as sample pH, concentration of APDC and effect of potential interferents were established. Dried microdroplets (7 μL) of the obtained extracts were ablated from a polystyrene substrate and quantitated by ICP-MS. External calibration was used in combination with platinum (195Pt) as an internal standard. No matrix-matched standards are required to perform quantitative analysis. Proposed methodology yields sufficiently low detection limits (0.11 and 0.31 μg L-1 for 52Cr and 53Cr, respectively) with precision between 4 and 8%. The method was applied to determine Cr(VI) in tap and river samples. The spike recoveries showed acceptable performance of the method, with all of the recoveries within 7% of the nominal spike values.
Export Options
About this article
Cite this article as:
Razmislevicien Ina, Padarauskas Audrius, Pranaityt Birut and Naujalis Evaldas, Determination of Cr(VI) by Dispersive Liquid-Liquid Microextraction and Dried-Droplet Laser Ablation ICP-MS, Current Analytical Chemistry 2010; 6 (4) . https://dx.doi.org/10.2174/1573411011006040310
DOI https://dx.doi.org/10.2174/1573411011006040310 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Implication of Oncogenic Signaling Pathways as a Treatment Strategy for Neurodegenerative Disorders – Contemporary Approaches
CNS & Neurological Disorders - Drug Targets In Vivo DNA Electrotransfer for Immunotherapy of Cancer and Neurodegenerative Diseases
Current Drug Metabolism Structure and Function of the Nur77 Receptor Subfamily, a Unique Class of Hormone Nuclear Receptors
Current Genomics Roles of Chemokine CXCL12 and its Receptors in Ischemic Stroke
Current Drug Targets Development of Polymeric Prodrugs as a Therapeutic Agent for Alzheimers Disease by Mechanochemical Solid-State Polymerization
Current Medicinal Chemistry - Central Nervous System Agents Restoration of the Striatal Dopamine Synthesis for Parkinsons Disease:Viral Vector-Mediated Enzyme Replacement Strategy
Current Gene Therapy Medicinal Perspective of Indole Derivatives: Recent Developments and Structure-Activity Relationship Studies
Current Drug Targets A Path to Development or Demise ?
Current Neurovascular Research Meet Our Editorial Board Member
Current Psychiatry Reviews The Importance of the Structural Similarity of Drugs Used for Depression and Inflammation, Two Comorbid Diseases
Current Topics in Medicinal Chemistry Reduction of Oxidative/Nitrosative Stress in Brain and its Involvement in the Neuroprotective Effect of n-3 PUFA in Alzheimer’s Disease
Current Alzheimer Research Visual Sexual Stimulation and Erection, a Brief Review with New fMRI Data
Current Medicinal Chemistry Is There a Role for Cytokine Based Therapies in Fibromyalgia
Current Pharmaceutical Design The Toll-Like Receptor Radical Cycle Pathway: A New Drug Target in Immune-Related Chronic Fatigue
CNS & Neurological Disorders - Drug Targets Prediction of Enzyme’s Family Based on Protein-Protein Interaction Network
Current Bioinformatics Editorial [ New Advances in Alzheimers Disease: From Biology to Therapy Guest Editor: Giuseppina Tesco ]
Current Genomics Alzheimer’s Disease and Autistic Spectrum Disorder: Is there any Association?
CNS & Neurological Disorders - Drug Targets Objective Assessment of the Rheological Muscle Property in the Treatment of Fibromyalgia
Endocrine, Metabolic & Immune Disorders - Drug Targets Apoptosis Induction by Thalidomide: Critical for Limb Teratogenicity but Therapeutic Potential in Idiopathic Pulmonary Fibrosis?
Current Molecular Pharmacology From Presenilinase to γ-Secretase, Cleave to Capacitate
Current Alzheimer Research